doi:10.1001/jama.2013.4997 Paterson Christopher A, ORourke Melinda C
Patients already avoiding steroids due to hepatic or renal concerns should be evaluated carefully, as the combined metabolic load of an aggressive peptide protocol warrants individual assessment
Bonilla, E., Medina-Leendertz, S., Mora, M., Vielma, J
Side effects are usually mild and temporary some patients feel slight nausea, dizziness or a headache during an IV drip, or minor tenderness at the injection site
Comparative effectiveness research with established therapies would help determine the relative benefits and risks of these peptides compared to current standard treatments and would inform evidence-based treatment decisions